Log In
Print this Print this

biosimilar pegfilgrastim (LA-EP2006)

  Manage Alerts
Collapse Summary General Information
Company Novartis AG
DescriptionBiosimilar of pegfilgrastim, a pegylated G-CSF
Molecular Target Granulocyte colony-stimulating factor (G-CSF) receptor (CSF3R) (CD114)
Mechanism of ActionGranulocyte colony stimulating factor (G-CSF) receptor (CD114) agonist; Biosimilar
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentRegistration
Standard IndicationNeutropenia
Indication DetailsReduce the duration of chemotherapy-induced neutropenia (CIN); Treat neutropenia
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today